Posted on Friday, June 29, 2018 7:41 PM
This week, CMS denied Massachusetts’ request to pick and choose which drugs it will cover. It was an attempt for the state to try to rein in increasing drug prices.
If it had been approved, it would have been the first state allowed to create a list of approved drugs. But the agency said the state would have to forgo all manufacturer rebates under the plan, and the state had wanted to continue receiving them.
“We appreciate Massachusetts’ efforts to tackle skyrocketing drug prices and look forward to working with the commonwealth to meet its goals of effectively managing its Medicaid pharmacy benefit,” said CMS Administrator Seema Verma in a statement Wednesday.
Click here for the full article.
About Corridor
Corridor is the nation’s preferred partner and trusted business advisor to home health and hospice providers, providing quality services and impactful results for 30 years. Focusing on key operational, regulatory and financial challenges, Corridor delivering industry-unique solutions and deep expertise in coding, clinical documentation review, compliance, billing and collections , consulting and provider staff education . At Corridor, we make the business of caring for people Better! For the most important industry updates and news that impacts home health and hospice, please make sure to sign up for our weekly newsletter to receive the latest up-to-date industry information direct to your inbox!
For additional information, please contact Corridor at 1-866-263-3795.
